The last years, the efforts of developing antibody-based drugs for treatment of complex diseases are maintaining on a high level. Here are some examples that have been published in the mainstream media the last six months:
- Antibodies against antibiotic-resistant bacteria is developing as a complement to current antibiotics
- New antibody-based drugs are developing as a treatment against ALS
- Anti-HIV antibody cocktail is developing as protection against early HIV-infection
- Antibodies against cancer growth and malignancy are being developed by several research teams
As the technology for large-scale antibody manufacturing is advancing and becoming more efficient, the production is on its way of getting more cost-effective. This is a positive development for health care budgets and pharma companies, and last and most important, for all patients.
- Antibodies against antibiotic-resistant bacteria is developing as a complement to current antibiotics
- New antibody-based drugs are developing as a treatment against ALS
- Anti-HIV antibody cocktail is developing as protection against early HIV-infection
- Antibodies against cancer growth and malignancy are being developed by several research teams
As the technology for large-scale antibody manufacturing is advancing and becoming more efficient, the production is on its way of getting more cost-effective. This is a positive development for health care budgets and pharma companies, and last and most important, for all patients.
RSS Feed